BIIB Balance Sheet

Click line-items for a historical chart and %
Current assets:
Cash and cash equivalents 570.72M
Marketable securities 1.13B
Accounts receivable, net 686.85M
Due from unconsolidated joint business 268.4M
Inventory 447.37M
Other current assets 136.01M
Total current assets 3.24B
Marketable securities 2.04B
Property, plant and equipment, net 1.74B
Intangible assets, net 1.63B
Goodwill 1.2B
Investments and other assets 274.05M
Total assets 10.13B
Current liabilities:
Current portion of notes payable, line of credit and other financing arrangements 453.38M
Taxes payable 20.07M
Accounts payable 204M
Accrued expenses and other 979.95M
Total current liabilities 1.66B
Notes payable and line of credit 687.4M
Long-term deferred tax liability 217.27M
Other long-term liabilities 604.27M
Total liabilities 3.17B
Commitments and contingencies (Notes 2, 11, 16, 18 and 20) 0
Biogen Idec Inc. shareholders' equity
Preferred stock, par value $0.001 per share 0
Common stock, par value $0.0005 per share 127K
Additional paid-in capital 3.85B
Accumulated other comprehensive income (loss) -55.31M
Retained earnings 4.49B
Treasury stock, at cost -1.32B
Total Biogen Idec Inc. shareholders' equity 6.96B
Noncontrolling interests 2.27M
Total equity 6.96B
Total liabilities and equity 10.13B

Entities mentioned with BIIB

View All Entities